Recombinant Human DTYMK Protein，His

DTYMK, or Deoxythymidylate Kinase, is a crucial enzyme involved in the regulation of deoxyribonucleotide metabolism, playing a vital role in DNA synthesis and repair. As a key player in the salvage pathway of nucleotide metabolism, DTYMK catalyzes the phosphorylation of deoxythymidine monophosphate (dTMP) to deoxythymidine diphosphate (dTDP), thus providing a direct source of deoxythymidine nucleotides necessary for DNA replication and cell division. Given its pivotal function, DTYMK has garnered attention in cancer research, as tumor cells often exhibit altered nucleotide metabolism to support their rapid proliferation. Additionally, the enzyme's structure and function make it a potential target for therapeutic intervention, as inhibiting DTYMK could disrupt tumor growth by depriving cancer cells of essential nucleotides. Advances in protein engineering and structural biology have facilitated the investigation of DTYMK’s properties, shedding light on its enzymatic mechanisms and paving the way for the development of novel inhibitors. Understanding the biochemical pathways involving DTYMK can help in designing targeted treatments for cancers characterized by dysregulated nucleotide metabolism, ultimately contributing to more effective cancer therapies. Thus, ongoing research into DTYMK not only enhances the fundamental knowledge of nucleotide biochemistry but also opens new avenues for drug discovery in oncology.